Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)
NCT04704713 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2021-03-19
Summary
This study was to evaluate the safety and efficacy of afamelanotide in patients suffering from polymorphic light eruption (PLE).
Conditions
- Polymorphic Light Eruption
Interventions
- DRUG
-
Afamelanotide
- DRUG
Sponsors & Collaborators
-
Clinuvel Pharmaceuticals Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-05
- Primary Completion
- 2010-12-09
More Related Trials
-
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD
NCT04770545 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
NCT07215390 ·Status: RECRUITING ·Phase: PHASE2
-
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
NCT00157976 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration
NCT01691261 ·Status: COMPLETED ·Phase: PHASE1
-
Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD
NCT03479372 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
NCT03525600 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
NCT02461771 ·Status: COMPLETED ·Phase: PHASE1
-
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
NCT06373731 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
NCT00414206 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]
NCT04270747 ·Status: COMPLETED ·Phase: PHASE3
-
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
NCT05230537 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
NCT04065490 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
NCT05949593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase II/III Study of Anti-VEGF in Neovascular AMD
NCT00021736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
NCT01624636 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT02087085 ·Status: TERMINATED ·Phase: PHASE2
-
CLN-0046: Treatment of AMD Subjects With OTX-TKI
NCT03630315 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration
NCT01033721 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion
NCT01889251 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety of RVL-1201 in Treatment of Blepharoptosis
NCT03536949 ·Status: COMPLETED ·Phase: PHASE3
-
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05769153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma
NCT05706896 ·Status: RECRUITING ·Phase: NA
-
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
NCT03891875 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
NCT07330674 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
NCT00447980 ·Status: COMPLETED ·Phase: PHASE2